Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Open Label Study of BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Patients With Chronic Migraine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03193359
Recruitment Status : Withdrawn (Corporate Decision)
First Posted : June 20, 2017
Last Update Posted : July 14, 2017
Sponsor:
Information provided by (Responsible Party):
Allergan

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : September 9, 2021
Estimated Study Completion Date : September 9, 2021